Colorectal Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Colorectal Cancer, including details on symptoms, genetics, screening, treatment, information.

Volume 3 (2006), Issue 11 (November)

1. Long-term aspirin use and colorectal cancer risk: a cohort study in Sweden.
   Br J Cancer, 95(9): 1277-9. [Abstract] [Full-text]
2. Cost-effectiveness of oxaliplatin and capecitabine in the adjuvant treatment of stage III colon cancer.
   Br J Cancer, 95(9): 1195-201. [Abstract] [Full-text]
3. The role of MYH and microsatellite instability in the development of sporadic colorectal cancer.
   Br J Cancer, 95(9): 1239-43. [Abstract] [Full-text]
4. Repeated cycles of Clostridium-directed enzyme prodrug therapy result in sustained antitumour effects in vivo.
   Br J Cancer, 95(9): 1212-9. [Abstract] [Full-text]
5. Dietary intake of calcium, fiber and other micronutrients in relation to colorectal cancer risk: Results from the Shanghai Women's Health Study.
   Int J Cancer, 119(12): 2938-42. [Abstract] [Full-text]
6. Enhanced expression of cholecystokinin-2 receptor promotes the progression of colon cancer through activation of focal adhesion kinase.
   Int J Cancer, 119(12): 2724-32. [Abstract] [Full-text]
7. Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia.
   N Engl J Med, 355(18): 1863-72. [Abstract] [Full-text]
8. Modulation of oncogenic transcription and alternative splicing by beta-catenin and an RNA aptamer in colon cancer cells.
   Cancer Res, 66(21): 10560-6. [Abstract] [Full-text]
9. Genetic instability on chromosome 17 in the epithelium of non-polypoid colorectal carcinomas compared to polypoid lesions.
   Cancer Sci, 97(12): 1335-42. [Abstract] [Full-text]
10. Antivascular effects of TZT-1027 (Soblidotin) on murine Colon26 adenocarcinoma.
    Cancer Sci, 97(12): 1410-6. [Abstract] [Full-text]
11. Efforts to improve local control in rectal cancer compromise survival by the potential morbidity of optimal mesorectal excision.
    J Am Coll Surg, 203(5): 684-91. [Abstract] [Full-text]
12. Chemotherapeutic agents for colorectal cancer with a defective mismatch repair system: the state of the art.
    Cancer Treat Rev, 32(8): 607-18. [Abstract] [Full-text]
13. Cell number-dependent regulation of Hsp70B' expression: evidence of an extracellular regulator.
    J Cell Physiol, 210(1): 201-11. [Abstract] [Full-text]
14. Expression of the mitotic checkpoint gene MAD2L2 has prognostic significance in colon cancer.
    Int J Cancer, 120(1): 207-11. [Abstract] [Full-text]
15. The changing incidence and sites of colorectal cancer in the Israeli Arab population and their clinical implications.
    Int J Cancer, 120(1): 147-51. [Abstract] [Full-text]
16. Correlation between hypermethylation of the RASSF2A promoter and K-ras/BRAF mutations in microsatellite-stable colorectal cancers.
    Int J Cancer, 120(1): 7-12. [Abstract] [Full-text]
17. SULT1A1 genotype and susceptibility to colorectal cancer.
    Int J Cancer, 120(1): 201-6. [Abstract] [Full-text]
18. Ruptured appendiceal cystadenoma presenting as right inguinal hernia in a patient with left colon cancer: a case report and review of literature.
    BMC Gastroenterol, 6: 32. [Abstract] [Full-text]
19. Enrichment of non-synchronized cells in the G1, S and G2 phases of the cell cycle for the study of apoptosis.
    Biochem Pharmacol, 72(11): 1396-404. [Abstract] [Full-text]
20. Influence of colorectal laparoscopic surgery on dissemination and seeding of tumor cells.
    Surg Endosc, 20(11): 1759-61. [Abstract] [Full-text]
21. Deoxycholic acid differentially regulates focal adhesion kinase phosphorylation: role of tyrosine phosphatase ShP2.
    Am J Physiol Gastrointest Liver Physiol, 291(6): G1100-12. [Abstract] [Full-text]
22. A novel DNA vaccine encoding PDGFRbeta suppresses growth and dissemination of murine colon, lung and breast carcinoma.
    Vaccine, 24(47): 6994-7002. [Abstract] [Full-text]
23. Stage-specific alterations of the genome, transcriptome, and proteome during colorectal carcinogenesis.
    Genes Chromosomes Cancer, 46(1): 10-26. [Abstract] [Full-text]
24. The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor signaling in colon cancer.
    Gastroenterology, 131(5): 1486-500. [Abstract] [Full-text]
25. Aristaless-like homeobox-4 gene methylation is a potential marker for colorectal adenocarcinomas.
    Gastroenterology, 131(5): 1418-30. [Abstract] [Full-text]
26. Pathogenicity of MSH2 missense mutations is typically associated with impaired repair capability of the mutated protein.
    Gastroenterology, 131(5): 1408-17. [Abstract] [Full-text]
27. High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy.
    Gastroenterology, 131(5): 1400-7. [Abstract] [Full-text]
28. Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer.
    J Natl Cancer Inst, 98(22): 1647-54. [Abstract] [Full-text]
29. Development of quality indicators for patients undergoing colorectal cancer surgery.
    J Natl Cancer Inst, 98(22): 1623-33. [Abstract] [Full-text]
30. Solid tumors subsequent to arsenic trioxide treatment for acute promyelocytic leukemia.
    Leuk Res, 31(1): 105-8. [Abstract] [Full-text]
31. Preoperative staging of rectal cancer: comparison of 3-T high-field MRI and endorectal sonography.
    AJR Am J Roentgenol, 187(6): 1557-62. [Abstract] [Full-text]
32. Palifermin reduces the incidence of oral mucositis in patients with metastatic colorectal cancer treated with fluorouracil-based chemotherapy.
    J Clin Oncol, 24(33): 5194-200. [Abstract] [Full-text]
33. Compensatory increases in Her-2/neu activation in response to EGFR tyrosine kinase inhibition in colon cancer cell lines.
    J Surg Res, 136(2): 227-31. [Abstract] [Full-text]
34. Establishment of a syngeneic model of hepatic colorectal oligometastases.
    J Surg Res, 136(2): 288-93. [Abstract] [Full-text]
35. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points.
    Am J Surg Pathol, 30(12): 1491-501. [Abstract] [Full-text]
36. A bacterial protein enhances the release and efficacy of liposomal cancer drugs.
    Science, 314(5803): 1308-11. [Abstract] [Full-text]
37. Telephone outreach to increase colorectal cancer screening in an urban minority population.
    Am J Public Health, 96(12): 2246-53. [Abstract] [Full-text]
38. Identification of mismatch repair gene mutations in young patients with colorectal cancer and in patients with multiple tumours associated with hereditary non-polyposis colorectal cancer.
    Gut, 55(12): 1781-8. [Abstract] [Full-text]
39. Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer.
    Cancer, 107(11): 2581-8. [Abstract] [Full-text]
40. Genetic testing for colon cancer.
    Nat Clin Pract Gastroenterol Hepatol, 3(12): 670-9. [Abstract] [Full-text]
41. Flax seed oil and flax seed meal reduce the formation of aberrant crypt foci (ACF) in azoxymethane-induced colon cancer in Fisher 344 male rats.
    Food Chem Toxicol, 45(1): 153-9. [Abstract] [Full-text]

© 2004-2008 Colorectal Cancer Research Today. All Rights Reserved.